Skip to main content
. 2019 Jul 23;42(10):881–888. doi: 10.1002/clc.23237

Table 1.

Clinical characteristics of patients with and without elevated hs‐cTnT

Variable hs‐cTnT >14 ng/L (n = 65) hs‐cTnT ≤14 ng/L (n = 176) P‐value
Age, years, mean (SD) 71.0 (10.7) 62.5 (9.5) <.001
Male sex, n (%) 49 (75.4) 130 (73.9) .811
ODT, minutes, mean (SD) 118.7 (61.7) 109.1 (56.1) .253
DNT, minutes, mean (SD) 66.9 (25.7) 65.0 (27.6) .620
ONT, minutes, mean (SD) 185.7 (61.0) 174.7 (57.3) .198
NIHSS on admission, median (IQR) 5.0 (2.0‐10.5) 3.0 (2.0‐6.0) .010
History
Smoking, n (%) 28 (43.1) 94 (53.4) .155
Alcohol abuse, n (%) 20 (30.8) 62 (35.2) .517
Hypertension, n (%) 48 (73.8) 115 (65.3) .210
Hyperlipidemia, n (%) 33 (50.8) 87 (49.4) .854
Diabetes mellitus, n (%) 25 (38.5) 40 (22.7) .015
Coronary artery disease, n (%) 25 (38.5) 38 (21.6) .008
Previous MI history, n (%) 7 (10.8) 9 (5.1) .118
Atrial fibrillation, n (%) 16 (24.6) 16 (9.1) .002
Congestive heart failure, n (%) 8 (12.3) 11 (6.3) .121
Previous stroke, n (%) 17 (26.2) 44 (25.0) .855
Chronic obstructive pulmonary disease, n (%) 0 (0.0) 2 (1.1) .388
Epilepsy, n (%) 1 (1.5) 2 (1.1) 1.000
Creatinine, μmol/L, mean (SD) 81.2 (31.2) 71.9 (20.3) .008
eGFR (mL/min/1.73 m2), mean (SD) 81.5 (22.1) 94.5 (19.7) <.001
Glucose (mmol/L), mean (SD) 8.8 (3.7) 7.9 (3.3) .092
Insular cortex involvement, n (%) 17 (26.2) 21 (11.9) .007
Right insula involvement, n (%) 8 (47.1) 15 (71.4) .127
Stroke etiology (TOAST) .001
Cardioembolic, n (%) 36 (55.4) 72 (40.9)
Small‐vessel disease, n (%) 11 (16.9) 9 (5.1)
Large‐artery arteriosclerosis, n (%) 13 (20.0) 75 (42.6)
Undefined, n (%) 5 (7.7) 18 (10.2)
Other defined, n (%) 0 (0.0) 2 (1.1)

Abbreviations: eGFR, estimated glomerular filtration rate; hs‐cTnT, high‐sensitivity cardiac troponin T; IQR, interquartile range; MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; ODT, onset‐to‐door time; DNT, door‐to‐needle time; ONT, onset‐to‐needle time.